In vitro to in vivo extrapolation of the complex drug-drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation

The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America

Scott Grimm, Heidi J. Einolf, Steven D. Hall et al. · Drug Metabolism and Disposition · 2009 · 306 citations

Medicine, Pharmacokinetics, Pharmacology +17

A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro

Odette A. Fahmi, Tristan S. Maurer, Mary Kish et al. · Drug Metabolism and Disposition · 2008 · 199 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

K. Br�sen, J G Hansen, Karin Kramer Nielsen et al. · European Journal of Clinical Pharmacology · 1993 · 193 citations

Medicine, Pharmacology, Pharmacotherapy +13

Inhibition of CYP2D6 Activity by Bupropion

Michael Kotlyar, Lisa H. Brauer, Timothy S. Tracy et al. · Journal of Clinical Psychopharmacology · 2005 · 140 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +13

Combining Bupropion SR With Venlafaxine, Paroxetine, or Fluoxetine

Sidney H. Kennedy, Sonia McCann, Mario Masellis et al. · The Journal of Clinical Psychiatry · 2002 · 135 citations

Pharmacy, Pharmacotherapy, Psychiatry +15